Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING


OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023


- AND -


MANAGEMENT INFORMATION CIRCULAR





... | April 6, 2023

Related Keywords

United States ,Toronto ,Ontario ,Canada ,United Kingdom ,Germany ,New York ,Ohio ,Massachusetts ,New Jersey ,Broadridge ,Pennsylvania ,Guelph ,Louisiana ,Munich ,Bayern ,Princeton University ,University Of Dayton ,Ireland ,Calgary ,Alberta ,America ,Canadians ,Canadian ,Irish ,Leonard Kruimer ,Matt Coffey ,Bristol Myers Squibb ,Thomasc Heineman ,Jonathan Rigby ,Allison Hagerman ,Deborah Brown ,Michael Bennett ,Wayne Pisano ,Deborahm Brown ,Jamest Parsons ,Aptose Biosciences ,James Parsons ,Matthewc Coffey ,Bernd Seizinger ,Revolo Biotherapeutics ,Sanofi Pasteur ,Angela Holtham ,Berndr Seizinger ,Management Of The Corporation ,Novartis ,Oncolytics Biotech Inc ,Aptose Biosciences Inc ,Sheffield University ,United States Securities Exchange ,Member Of The Compensation Committee ,Compensation Or Science Development Committee ,Toronto Stock Exchange ,Opsona Therapeutics Ltd ,University Of Guelph ,Diamedica Therapeutics Inc ,Biotech Us Inc ,Provention Bio Inc ,Zogenix Inc ,National Pharmaceutical Organization ,Harvard Medical School ,Science Development ,Health Care Index ,Institute Of Corporate Directors Designation ,Affairs Of The Board ,Common Shares Of The Corporation ,Steadymed Ltd ,National Instrument ,Broadridge Financial Solutions Inc ,Peer Group ,Audit Committee ,Science Development Committee ,Number Of Directors The Corporation ,Member Of The Audit Committee ,Rotman School Of Management ,Aon Hewitt Corporation Radford ,Member Of The Science Development Committee ,Articles Of Incorporation The Corporation ,Laws Of The Corporation ,Corporation Peer Group ,Trust Company ,Altimmune Inc ,University Of Calgary ,Nasdaq ,Aprea Therapeutics Inc ,Sernova Corp ,John Fisher College ,Portsmouth University ,Nabisco Inc ,Governance Committee ,Rigby ,University Of Toronto ,Bioplus Acquisition Corp ,Global Head Of Clinical Development ,Officers Of The Corporation ,Corporation Management ,Corporation Stock Option Plan ,Technology Committee ,Compensation Committee ,Bioinvent International ,Serono ,Incentive Program ,United Therapeutics Corporation ,Governance Compensation Committee ,Amorfix Life Sciences Ltd ,Us Exchange ,Honors In Biological Sciences ,University School Of Business ,Trillium Therapeutics Inc ,Audit Committees Of Sernova Corp ,Product Development ,Corporation Share Award Plan ,Oncolytics Biotech Us Inc ,Corporation At Suite ,Member Of The Governance Committee ,Annual Meeting ,Special Meeting ,Management Information Circular ,Investor Relations ,Management Information ,Chief Executive Officer ,Oncolytics Biotech ,Annual General Meeting ,Registered Shareholder ,Common Shares ,Control Number ,North America ,Toronto Time ,Beneficial Shareholder ,Registered Shareholders ,Beneficial Shareholders ,Transfer Agent ,United States Securities Exchange Act ,Beneficial Owners ,Reporting Issuer ,Notice And Access Provisions ,Canadian Securities Administrators ,Broadridge Financial Solutions ,Stock Option Plan ,Share Award Plan ,Vote Your Common ,Common Share ,Record Date ,Financial Statements ,Auditor Report ,Date Appointed ,Principal Occupation ,Preceding Five Years ,Canadian Strategic Partnerships ,Executive Vice President ,Managing Director ,Innovative Medicines Canada ,Western University ,Corporate Directors Designation ,Human Gene Therapy ,Chief Operating Officer ,Chief Scientific Officer ,Chief Financial Officer ,Senior Vice President ,Chief Financial ,Ontario Based Hospital ,Sick Children ,Vice President ,Trillium Therapeutics ,Lorus Therapeutics ,Audit Committees ,Diamedica Therapeutics ,Group Chief Executive Officer ,United Therapeutics ,Profile Therapeutics ,Phillips Medical ,Immunomolecular Therapeutics Boards ,Biological Sciences ,Oncology Drug Discovery ,Academic Alliances ,Massachusetts General ,Aprea Therapeutics ,Nykode Therapeutics ,Majority Voting Policy ,Cease Trade Orders ,Unallocated Options Under ,Stock Option ,Share Awards ,Share Award ,Equity Incentive Plans ,Increase Maximum Number ,Shares Available ,Equity Incentive ,Equity Incentive Plan ,Stock Options ,Approval Requirement ,Chartered Accountants ,Named Executive Officer ,Named Executive Officers ,Option Grants ,Share Award Grants ,Chief Medical Officer ,Executive Compensation Related Fees ,Compensation Related ,Global Head ,Clinical Development ,Learned During ,Development Committee ,Share Based Awards ,Option Based Awards ,Exercise Price ,Eligible Person ,Eligible Persons ,Acted Upon ,Vesting Percentage ,Share Awards Agreements ,Cessation Date ,Compensation Plan Information ,Each Employment Agreement ,Employment Agreements ,Cause Severance ,Control Severance ,Development Committees ,Continuing Education ,Board Members ,Canadian System ,Electronic Document Analysis ,Board Diversity Policy ,Business Corporations Act ,Aboard March ,Corporate Secretary ,Human Resources ,Oncolytics Biotech Inc Stock Exchange ,News ,Information ,Press Release ,Notice ,F ,Nnual ,Eneral ,Shareholders ,O ,The ,Held ,N ,Bay ,End ,Management ,Nformation Onc Ca6823108759 ,